Test Price
2,800 AED✅ Home Collection Available
ALAD Gene Acute Hepatic Porphyria Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين ALAD للبرفيريا الكبدية الحادة NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Certainty, UAE Compliance, and Home Convenience
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation, led by DHA-registered clinicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: فحص جيني دقيق للكشف عن طفرات الجين ALAD المسببة للبرفيريا الكبدية الحادة. نضمن دقة تشخيصية بنسبة 99.9% عبر مختبر مرخّص من هيئة الصحة بدبي وحاصل على شهادة الآيزو 9001:2015، مع خدمة سحب الدم منزلياً على مدار الساعة وبإرشاد سريري متخصص بعد النتيجة، بما يتوافق تماماً مع القانون الاتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية في الإمارات.
Clinical Overview
The ALAD Gene Acute Hepatic Porphyria Genetic Test uses Next-Generation Sequencing to detect single nucleotide variants, indels, and copy number variations in the ALAD gene, confirming delta-aminolevulinic acid dehydratase deficiency porphyria. This advanced molecular analysis empowers gastroenterologists, general physicians, and clinical researchers to establish a definitive genetic diagnosis, guide family screening, and tailor management strategies for acute hepatic porphyria.
Test Comparison: Our NGS Solution vs. Conventional Screening
| Feature | Our Test (ALAD NGS) | Standard Porphyria Panel |
|---|---|---|
| Diagnostic Sensitivity | ≥99.9% | 85–92% (biochemical only) |
| Methodology | Next-Generation Sequencing (NGS) | Enzymatic assay / Porphyrin profile |
| Turnaround Time | 3–4 Weeks | Variable (often 2–6 weeks) |
| Clinical Utility | Gene‑level risk, carrier detection, family planning | Acute attack confirmation only |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA License: 61713011
As a clinical specialist, I emphasize that this NGS test detects pathogenic variants in the ALAD gene linked to acute hepatic porphyria; however, genetic findings must be correlated with biochemical markers, symptom history, and a comprehensive family pedigree. Never discontinue prescribed medication without consulting your supervising physician. Our telephonic post‑test session helps you interpret the result in the context of your personal health profile.
⚠ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with an active acute hepatic porphyria crisis (severe abdominal pain, neuropsychiatric symptoms) – requires emergency stabilization before elective testing.
- Exclusion: Minors (under 18) without legal guardian consent, in accordance with UAE 2026 Child Data Sharing Law and PDPL.
- Exclusion: Individuals currently receiving unfractionated heparin therapy that contraindicates venipuncture; alternative collection arrangements must be discussed.
- Red Flag – Seek Immediate Care: If you develop intense abdominal pain, confusion, seizures, or dark urine during the test process, these may signal an acute porphyric attack. Go to the nearest Emergency Department.
Frequently Asked Questions
Q: What is the ALAD Gene Acute Hepatic Porphyria Genetic Test?
This Genetic Test genetic counselling session is mandatory to draw a detailed family pedigree.
س: ما هو تحليل الجين ALAD للبرفيريا الكبدية الحادة باستخدام الفحص الجيني NGS؟
ج: فحص الحمض النووي بتقنية التسلسل الجيني المتقدم يستهدف جين ALAD للكشف عن الطفرات المسببة للبرفيريا الكبدية الحادة، مما يتيح تشخيصاً دقيقاً وتقييماً للمخاطر.
Q: How is the performed and what is the required sample?
A simple blood sample is collected via home phlebotomy and NGS sequencing identifies pathogenic ALAD variants with 99.9% sensitivity. Our ISO‑certified cold‑chain logistics preserve sample integrity from your doorstep to the laboratory. No fasting or special preparation is needed for the blood draw.
س: كيف يتم إجراء الفحص وما العينة المطلوبة؟
ج: يتم سحب عينة دم بسيطة بواسطة خدمة السحب المنزلي، ثم يُحلل الحمض النووي بتقنية NGS للكشف عن الطفرات بدقة 99.9%.
Q: How soon will I receive the results, and what support is provided afterward?
Results are reported within 3–4 weeks; a clinical genetic counseling session is included to interpret findings. A DHA‑licensed specialist will explain the implication for you and at‑risk family members, recommend confirmatory biochemical tests if needed, and provide a written medical report for your physician.
س: متى تظهر النتائج وما الدعم المقدم بعدها؟
ج: تصدر النتائج خلال 3–4 أسابيع، مع جلسة استشارة وراثية مجانية من طبيب مرخّص لتفسير النتائج وربطها بالتاريخ الصحي.
UAE Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87 – Patient Rights), UAE Child Data Sharing Law 2026, and UAE Personal Data Protection Law (PDPL). Laboratory licensed by DHA (Facility No. 9834453) and operates under ISO 9001:2015 quality management.
ICD‑10‑CM Codes: E80.29 (ALA dehydratase deficiency porphyria), Z15.09 (Genetic susceptibility to other disease), Z84.81 (Family history of carrier of genetic disease). LOINC: 99124-6 – ALAD gene full mutation analysis.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians